Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7076
PUT
Alkermes
ALKS
$8.3B
| $935K | ﹤0.01% |
31,400
+6,000
| +24% | +$172K |
|
7077
CALL
Bitwise Crypto Industry Innovators ETF
BITQ
$374M
| $935K | ﹤0.01% |
168,500
+120,800
| +253% | +$1.22M |
|
7078
CALL
Kimco Realty
KIM
$16.2B
| $935K | ﹤0.01% |
47,300
+14,100
| +42% | +$324K |
|
7079
PUT
MakeMyTrip
MMYT
$5.59B
| $935K | ﹤0.01% |
36,400
+28,100
| +339% | +$725K |
|
|
SAND
7080
PUT
DELISTED
Sandstorm Gold
SAND
| $935K | ﹤0.01% |
157,200
-9,100
| -5% | -$64.6K |
|
7081
PUT
iShare MSCI Eurozone ETF
EZU
$9.9B
| $934K | ﹤0.01% |
25,700
-123,700
| -83% | -$4.95M |
|
7082
CALL
Methanex
MEOH
$4.45B
| $933K | ﹤0.01% |
24,400
-56,900
| -70% | -$2.8M |
|
7083
ProShares UltraShort MidCap400
MZZ
$4.12M
| $933K | ﹤0.01% |
+43,813
| New | +$819K |
|
|
AKRO
7084
DELISTED
Akero Therapeutics
AKRO
| $932K | ﹤0.01% |
98,610
+10,800
| +12% | +$113K |
|
7085
Flex
FLEX
$44.4B
| $932K | ﹤0.01% |
85,489
+51,068
| +148% | +$633K |
|
|
KREF
7086
CALL
KKR Real Estate Finance Trust
KREF
$468M
| $932K | ﹤0.01% |
53,400
+28,900
| +118% | +$557K |
|
|
MDC
7087
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
| $931K | ﹤0.01% |
28,800
-17,400
| -38% | -$623K |
|
|
TA
7088
CALL
DELISTED
TravelCenters of America LLC
TA
| $931K | ﹤0.01% |
27,000
+10,000
| +59% | +$371K |
|
7089
CALL
Essent Group
ESNT
$6.25B
| $930K | ﹤0.01% |
23,900
+10,800
| +82% | +$441K |
|
|
KYNB
7090
Kyntra Bio
KYNB
$28.4M
| $930K | ﹤0.01% |
3,521
+2,306
| +190% | +$589K |
|
7091
PUT
Ramaco Resources Class A
METC
$735M
| $930K | ﹤0.01% |
73,075
-13,850
| -16% | -$208K |
|
|
WCN
7092
CALL
Waste Connections
WCN
$41.6B
| $930K | ﹤0.01% |
7,500
-21,000
| -74% | -$2.72M |
|
|
AMTI
7093
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $930K | ﹤0.01% |
319,565
+229,114
| +253% | +$963K |
|
7094
Matrix Service
MTRX
$328M
| $929K | ﹤0.01% |
183,568
-38,531
| -17% | -$242K |
|
7095
Weibo
WB
$1.86B
| $929K | ﹤0.01% |
40,166
+4,849
| +14% | +$109K |
|
7096
CALL
Clearwater Paper
CLW
$333M
| $928K | ﹤0.01% |
27,600
+2,400
| +10% | +$75.1K |
|
7097
PUT
Direxion Daily Healthcare Bull 3X ETF
CURE
$194M
| $928K | ﹤0.01% |
9,000
-5,600
| -38% | -$631K |
|
7098
ALPS Strategic Income Fund
RIGS
$60.4M
| $928K | ﹤0.01% |
40,928
+27,659
| +208% | +$640K |
|
7099
Allogene Therapeutics
ALLO
$701M
| $927K | ﹤0.01% |
81,363
-2,534,748
| -97% | -$22.5M |
|
7100
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$107M
| $927K | ﹤0.01% |
29,454
+5,832
| +25% | +$202K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.